Search results
Results From The WOW.Com Content Network
The National Institutes of Health Stroke Scale, or NIH Stroke Scale (NIHSS), is a tool used by healthcare providers to objectively quantify the impairment caused by a stroke and aid planning post-acute care disposition, though was intended to assess differences in interventions in clinical trials. The NIHSS was designed for the National ...
In an effort to achieve their goal, the NINDS "supports and conducts research, both basic and clinical, on the normal and diseased nervous system, fosters the training of investigators in the basic and clinical neurosciences, and seeks better understanding, diagnosis, treatment, and prevention of neurological disorders." [1]
Research and training aimed to eliminate the suffering and death due to cancer. 1937 $5,081.8 www.cancer.gov: National Institute of Allergy and Infectious Diseases: NIAID Research goals include striving to understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases.
The National Institutes of Health (NIH) is the primary agency of the United States government responsible for biomedical and public health research. It was founded in 1887 and is now part of the United States Department of Health and Human Services.
The Cincinnati Prehospital Stroke Scale (abbreviated CPSS) is a system used to diagnose a potential stroke in a prehospital setting. [1] It tests three signs for abnormal findings which may indicate that the patient is having a stroke.
The multimedia mRS training system which was developed by Prof. K. Lees' group at the University of Glasgow is available online. The mRS is frequently criticized for its subjective nature which is viewed as skewing results, but is used throughout hospital systems to assess rehabilitation needs and outpatient course.
The NIH Clinical Center is a hospital solely dedicated to clinical research at the National Institutes of Health campus in Bethesda, Maryland.The Clinical Center, known as Building 10, consists of the original part of the hospital, the Warren Grant Magnuson Clinical Center, and the newest addition, the Mark O. Hatfield Clinical Research Center.
To complement the CHADS 2 score, by the inclusion of additional 'stroke risk modifier' risk factors, the CHA 2 DS 2-VASc-score has been proposed. [8]In clinical use, the CHADS 2 score has been superseded by the CHA 2 DS 2-VASc score, which gives a better stratification of low-risk patients.